Cancer Solutions Research Inc
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 118,033 | 101,269 | 16,764 | 9.1 | — |
| 2012 | 103,664 | 114,337 | −10,673 | 6.9 | — |
| 2013 | 64,340 | 82,436 | −18,096 | 7.0 | — |
| 2014 | 78,233 | 49,808 | 28,425 | 18.4 | — |
| 2015 | 28,450 | 39,800 | −11,350 | 19.7 | — |
| 2016 | 19,817 | 21,936 | −2,119 | 34.5 | — |
| 2017 | 25,777 | 20,999 | 4,778 | 9.0 | — |
| 2018 | 11,630 | 19,431 | −7,801 | 4.9 | — |
| 2019 | 7,353 | 14,943 | −7,590 | 0.2 | — |
| 2020 | 4,494 | 3,546 | 948 | 4.1 | — |
| 2021 | 15,790 | 6,955 | 8,835 | 17.4 | — |
| 2022 | 10,657 | 13,367 | −2,710 | 6.6 | — |
| 2023 | 23,368 | 18,952 | 4,416 | 7.4 | — |
In its most recent public year (2023), this organization brought in $4,416 more than it spent. Its reserves stood at about 7.4 months of spending, down from 9.1 in 2011.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Cancer Solutions Research Inc's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works